Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05110703 · ClinicalTrials.gov registry record · NA
Study to Assess Safety and Effect of a Prebiotic Fiber Meal Replacement Shake in Individuals With Type 2 Diabetes
A NA study of Diabetes Mellitus, Type 2, sponsored by Uplifting Results Labs.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
- 1
- Study location
NCT05110703 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Uplifting Results Labs. The registered enrollment target is 192 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05110703, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Uplifting Results Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a double-blind, randomized, trial of a commercially available meal-replacement shake versus a placebo control designed to evaluate the impact on quality of life, safety, and tolerability. It also includes a randomized, non-blinded third arm consisting of only dietary guidelines.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Supergut
- OTHER Dietary guidelines
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2022-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05110703
The ClinicalTrials.gov registry entry for NCT05110703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (96% lower). The listed sponsor is Uplifting Results Labs, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05110703 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05110703 about?
NCT05110703 is a clinical study titled "Study to Assess Safety and Effect of a Prebiotic Fiber Meal Replacement Shake in Individuals With Type 2 Diabetes". This study is a double-blind, randomized, trial of a commercially available meal-replacement shake versus a placebo control designed to evaluate the impact on quality of life, safety, and tolerability. It also includes a randomized, non-blinded third arm consisting of only dietary guidelines.
What is the current status of trial NCT05110703?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2021-10-11. Estimated completion is 2022-03-01.
What conditions does trial NCT05110703 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT05110703?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Supergut (DIETARY_SUPPLEMENT), Dietary guidelines (OTHER).
Who is sponsoring clinical trial NCT05110703?
This trial is sponsored by Uplifting Results Labs, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05110703 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.